Approval · Notice of Compliance 7970 · 2006
VAQTA: Notice of Compliance 7970
Issued May 18, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7970
- Date
- May 18, 2006
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Extension of age indication to include infants from 12 to 23 months
- Therapeutic class
- Active immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VAQTA | Not yet assigned | — |
Medicinal ingredients
- HEPATITIS A VACCINE, INACTIVATED 25 UNIT per 0.5ML
- HEPATITIS A VACCINE, INACTIVATED 50 UNIT per ML